WVPA's Pharmaceutical Crime Correspondent, Shabbir Safdar, from the Partnership for Safe Medicines, provides updates on the Aminov case (check out previous podcast episode for more information) and discusses recent trends in botox and semaglutide counterfeiting. We have a candid, funny discussion about why one should not purchase medications from ETSY - you don't want to miss this episode packed with interesting updates in the world of counterfeiting.

https://www.safemedicines.org/wp-content/uploads/2019/09/Govt-Sentencing-Memo-Aminov.pdf

Join us as we talk to Tommy Pile, PharmD, Monis Ali, and Lexi Atkinson from MUSOP about PBM Reform and how states are regulating pharmacy benefit managers in different ways.

See MUSOP Poster Presentation here:

Prescription for Reform: A Comparative Study of State Level Regulations on Pharmacy Benefit Managers by MUSOP (under Reimbursement)

Check out other reports and resources around PBM Reform here:

Trends in Profitability and Compensation of PBMs and PBM Contracted Entities by Nephron Research

Unraveling The Drug Pricing Blame Game by 3 Axis Advisors

Pharmacists United For Truth and Transparency

PBM Accountability Project

We sit down with Shabbir Safdar, Executive Director of Partnership for Safe Medicine, a public health group committed to the safety of prescription drugs and protecting consumers against counterfeit, substandard or otherwise unsafe medicines.

Shabbir will be a regular guest on our podcast throughout 2024 sharing stories of pharmaceutical counterfeiting and how we can prevent unsafe medicines from getting in our pharmacies and in the hands of our patients.

https://www.fda.gov/drugs/buying-using-medicine-safely/counterfeit-medicine

US vs. Aminov Indictments